Schonfeld Strategic Advisors’s ProKidney PROK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,845	Closed	-$58.8K	–	2920
2026 Q1	$58.8K	Buy	+32,845	New	+$69.7K	﹤0.01%	1948
2024 Q3	–	Sell	-11,800	Closed	-$29K	–	2346
2024 Q2	$29K	Buy	+11,800	New	+$31.7K	﹤0.01%	1982
2022 Q3	–	Sell	-42,852	Closed	-$426K	–	3122
2022 Q2	$426K	Hold	42,852	–	–	﹤0.01%	1451
2022 Q1	$424K	Buy	+42,852	New	+$423K	﹤0.01%	1473
2021 Q4	–	Sell	-400,000	Closed	-$3.92M	–	2452
2021 Q3	$3.92M	Hold	400,000	–	–	0.04%	506
2021 Q2	$4.04M	Buy	+400,000	New	+$4.04M	0.04%	519

Other funds holding PROK

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Schonfeld Strategic Advisors's PROK Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of ProKidney (PROK) in Q2 2026, closing a stake of 32,845 shares — an estimated $58.8K sold.

Schonfeld Strategic Advisors first reported a position in PROK in Q2 2021 and held it in 6 quarters. The position peaked at $4.04M in Q2 2021. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

Schonfeld Strategic Advisors reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
Schonfeld Strategic Advisors sold 32,845 ProKidney shares in Q2 2026, an estimated $58.8K.
Schonfeld Strategic Advisors first reported a position in ProKidney in Q2 2021 and held it in 6 quarters.
Schonfeld Strategic Advisors's ProKidney position peaked at $4.04M in Q2 2021.
71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.